Tomonori Araki

Nagasaki, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Esophageal cancer-associated thoracic central venous obstruction type 2 which occurred during chemoradiotherapy.

Esophageal cancer-associated thoracic central venous obstruction type 2 which occurred during chemoradiotherapy.

Journal: Internal medicine (Tokyo, Japan)
Published: August 26, 2026

Chemotherapy-induced neutropenia predicts short-term outcome of patients with pancreatic cancer treated with nanoliposomal irinotecan, fluorouracil, and folinic acid.

Chemotherapy-induced neutropenia predicts short-term outcome of patients with pancreatic cancer treated with nanoliposomal irinotecan, fluorouracil, and folinic acid.

Journal: International journal of cancer
Published: April 06, 2025

Drug-Induced Chylothorax During Chemotherapy With Ramucirumab and Paclitaxel for Advanced Gastric Cancer.

Drug-Induced Chylothorax During Chemotherapy With Ramucirumab and Paclitaxel for Advanced Gastric Cancer.

Journal: Cureus
Published: January 23, 2025

Comparison of inflammatory markers before and after nanoliposomal irinotecan and fluorouracil with folic acid in patients with pancreatic cancer: results from the NAPOLEON-2 study (NN-2302).

Comparison of inflammatory markers before and after nanoliposomal irinotecan and fluorouracil with folic acid in patients with pancreatic cancer: results from the NAPOLEON-2 study (NN-2302).

Journal: Therapeutic advances in medical oncology
Published: November 21, 2024

Real-World Analysis of the Correlation between Overall Survival and Progression-Free Survival in Advanced Pancreatic Cancer: Results of NAPOLEON-1 and 2 Studies.

Real-World Analysis of the Correlation between Overall Survival and Progression-Free Survival in Advanced Pancreatic Cancer: Results of NAPOLEON-1 and 2 Studies.

Journal: Oncology
Published: August 13, 2024

Long-term survival after conversion surgery for an esophageal neuroendocrine carcinoma: a case report.

Long-term survival after conversion surgery for an esophageal neuroendocrine carcinoma: a case report.

Journal: General thoracic and cardiovascular surgery cases
Published: January 19, 2024

Relationship between neutropenia caused by nanoliposomal irinotecan/fluorouracil/leucovorin and treatment outcomes in the NAPOLEON-2 study (NN-2301).

Relationship between neutropenia caused by nanoliposomal irinotecan/fluorouracil/leucovorin and treatment outcomes in the NAPOLEON-2 study (NN-2301).

Journal: Scientific reports
Published: September 29, 2023

Dabigatran-induced esophagitis with full circumferential blue pigmentation.

Dabigatran-induced esophagitis with full circumferential blue pigmentation.

Journal: DEN open
Published: May 18, 2023

Enhanced Cytotoxicity on Cancer Cells by Combinational Treatment of PARP Inhibitor and 5-Azadeoxycytidine Accompanying Distinct Transcriptional Profiles.

Enhanced Cytotoxicity on Cancer Cells by Combinational Treatment of PARP Inhibitor and 5-Azadeoxycytidine Accompanying Distinct Transcriptional Profiles.

Journal: Cancers
Published: June 05, 2022

Reduced Tumorigenicity of Mouse ES Cells and the Augmented Anti-Tumor Therapeutic Effects under Parg Deficiency.

Reduced Tumorigenicity of Mouse ES Cells and the Augmented Anti-Tumor Therapeutic Effects under Parg Deficiency.

Journal: Cancers
Published: April 07, 2020

Rectal Paraganglioma.

Rectal Paraganglioma.

Journal: Internal medicine (Tokyo, Japan)
Published: August 28, 2018

Amrubicin in patients with platinum-refractory metastatic neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma of the gastrointestinal tract.

Amrubicin in patients with platinum-refractory metastatic neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma of the gastrointestinal tract.

Journal: Anti-cancer drugs
Published: June 25, 2016
Showing 1-12 of 12

Last Updated: 09/26/2026